Fairey William 4
4 · KalVista Pharmaceuticals, Inc. · Filed Oct 2, 2025
Insider Transaction Report
Form 4
Fairey William
Director
Transactions
- Award
Stock Option (right to buy)
2025-10-01+30,000→ 30,000 totalExercise: $12.05Exp: 2035-09-30→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]The option vests over a 12 month period: 1/12th on November 1, 2025, after which 1/12th of the total shares vest monthly, subject to continued service through each vesting date.